Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
06/2006
06/21/2006EP1392325B1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
06/21/2006EP1366049B1 Pirazino¬1'2':1,6|pyrido¬3,4-b|indole derivatives
06/21/2006EP1268419B1 Pyrrolidine derivatives useful as bax inhibitors
06/21/2006EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
06/21/2006EP0909564B1 Erythropoietin solution preparation stabilized with amino acids
06/21/2006CN1791594A 2-aminoquinoline derivative
06/21/2006CN1791575A Cyanofluoropyrrolidine derivative.
06/21/2006CN1791429A Composition comprising a PDE4 inhibitor and a PDE5 inhibitor
06/21/2006CN1791414A Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders
06/21/2006CN1788784A Medicine for treating chronic prostatitis and its preparation method
06/21/2006CN1788611A Whole wood frog powder for removing fishy smell and its health product and its production method
06/21/2006CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/21/2006CN1260226C Tetrahydro-(benzo or thieno)-azepine-pyrazine and triazine derivatives as mGluR1 antagonists
06/21/2006CN1260222C Antagonists of mcp-1 function and methods of use thereof
06/21/2006CN1260215C Antagon of endostadin receptor pyrazole carboxylic acids
06/21/2006CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody
06/21/2006CN1259961C Medication for curing kidney disease and preparation method
06/21/2006CN1259956C Chinese medicine composition for treating heart, kidney and multiple-organ failure and its preparation
06/21/2006CN1259950C Chinese medical preparation and its preparing process
06/21/2006CN1259943C Prostate hyperplasia pharmaceutical and method for making same
06/21/2006CN1259932C Suppository for detoxicating and promoting blood circulation and its preparation method
06/21/2006CN1259925C Process for preparing compound coemzyme medicine and its compound coemzyme medicine and clinical use
06/21/2006CN1259914C Use of scopoletin in preparing medicine for preventing and curing hyperuricemia
06/20/2006US7064217 2-Aminoacetamide derivatives with hydroxy-, phosphonate-, and/or methylene phosphonate substituent; antitumor, anticoagulant, antiproliferative, and wound healing agents
06/20/2006US7064148 Such as 13,14-dihydro-15-keto-16,16-difluoro-prostaglandin E for treatment of cystic fibrosis; lubiprostone
06/20/2006US7064137 Analgesics; anxiolytic agents; gastrointestinal disorders
06/20/2006US7064134 4-piperidinyl-substituted, e.g., 4-(2-methyl-4-piperidin-1-yl-quinolin-7-ylmethoxy)-benzonitrile; treating eating disorders and obesity
06/20/2006US7064119 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence
06/20/2006US7063971 Phosphodiesterase enzymes
06/15/2006WO2006063178A2 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
06/15/2006WO2006061791A2 Novel diazabicyclononene derivative
06/15/2006WO2006061233A1 The use of medicament 4-(s)-(4-acetyl-piperazin-1-yl)-2-(r)-(4-fluoro-2-methyl-phenyl)-piperidine-1-carboxylic acid, [1-(r)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methylamide
06/15/2006WO2006026135A3 Substituted biaryl piperazinyl-pyridine analogues
06/15/2006US20060128807 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
06/15/2006US20060128781 Flavaxate derivatives as muscarinic receptor antagonists
06/15/2006US20060128780 Cyclic substituted fused pyrrolocarbazoles and isoindolones
06/15/2006US20060128755 3'-trifluoromethyl-3,4,5,6-tetrahydro-2H-[1,2']-bipyridinyl-4-carboxylic acid (4-isopropylphenyl)amide; antiinflammatory and analgesic
06/15/2006US20060128745 Chemical compounds
06/15/2006US20060128740 Tricyclic androgen receptor modulator compounds and methods
06/15/2006US20060128734 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea;
06/15/2006US20060128717 Therapeutic agents useful for treating pain
06/15/2006US20060128705 Method of treating chronic fatigue syndrome
06/15/2006US20060128704 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists
06/15/2006US20060128635 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
06/15/2006US20060128624 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
06/15/2006US20060128013 Directed differentiation of embryonic cells
06/15/2006US20060127900 Method for detecting increased susceptibility to tumors
06/15/2006US20060127445 Anti-angiogenic compositions and methods of use
06/15/2006US20060127395 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/15/2006US20060127378 Composition for promoting the proliferation of lactobacillus casei subsp. casei
06/15/2006US20060127353 Fat-binding polymers
06/15/2006US20060127319 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
06/15/2006CA2590711A1 Antagonists to the vanilloid receptor subtype 1 (vr1) and uses thereof
06/15/2006CA2590585A1 Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (vr1) and uses thereof
06/15/2006CA2589966A1 Novel diazabicyclononene derivative
06/14/2006EP1669450A1 Staple type oligonucleotide and drug comprising the same
06/14/2006EP1669350A1 Novel piperidine derivative
06/14/2006EP1669087A1 Preparation containing basic drug
06/14/2006EP1669076A1 Use of n-acetyl-d-aminoglycosamine in preparation of drugs for modulating microorganisms on mucous membrane
06/14/2006EP1667703A2 A composition and method of treatment for urogenital conditions
06/14/2006EP1476136B1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process for preparing thereof comprising dry granulation
06/14/2006EP1399439B1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
06/14/2006EP1341770B1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
06/14/2006EP1339683B1 Estrogen receptor modulators
06/14/2006EP1309703B1 Kallikrein gene
06/14/2006EP1165085B1 Phthalazine derivatives for treating inflammatory diseases
06/14/2006EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof
06/14/2006CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers
06/14/2006CN1786142A Medicinal wine
06/14/2006CN1786032A Erythrogenin/immune globulin Fc fusion protein, its sypthesis method and application
06/14/2006CN1786001A Composition stable blood porphrin derivative, its preparation method and injection agent
06/14/2006CN1785392A Chinese medicinal composition for treating prostatitis and its preparation method
06/14/2006CN1785381A Chinese medicine for treating calculus
06/14/2006CN1785377A Chinese medicinal preparation for treating urinary disense and its preparation method
06/14/2006CN1785345A Six ingredient rehmannia fast dispersion solid preparation and its preparation method
06/14/2006CN1785325A Ready prepared Chinese medicine for treating acute, chronic prostatitis and its preparation method
06/14/2006CN1785318A Chinese medicinal preparation for treating urethra infection
06/14/2006CN1785290A Lumbar invigorating kidney fortifying fast dispersion solid medicine and its preparation method
06/14/2006CN1785264A Chinese medicinal composition for treating strangury patterns and preparation method of its oral liquid, tablet and capsule
06/14/2006CN1785249A Novel use of medicine composition contg. red-rooted salvia
06/14/2006CN1785238A Application of pulvis pro clavus extractive total flavone in preparing anti-inflammatory agent
06/14/2006CN1785234A Medicine composition and its prepn. method
06/14/2006CN1785201A Panaxsaponin composition, prepn. method and use thereof
06/14/2006CN1785200A Notogisennoside composition, prepn. method and application thereof
06/14/2006CN1785193A Amino acid (-) ofloxacin water soluble salt
06/14/2006CN1259328C Isopamicin and its salt and their prepn
06/14/2006CN1259316C Heterocyclic compounds for aging-related and diabetic vascular complications
06/14/2006CN1259315C Antagonists of MCP-1 function and methods of use thereof
06/14/2006CN1259307C Acylated indanyl amines and their use as pharmaceuticals
06/14/2006CN1259084C Medicine for treating chronic nephritis and kidney disease and its preparation method
06/14/2006CN1259077C Medicine for treating urinary tract infection
06/14/2006CN1259000C Schisandra fruit vine peel drink and its preparation method
06/14/2006CN1258991C Schisandra fruit vine peel seasoning
06/13/2006US7060836 Lactams as tachykinin antagonists
06/13/2006US7060824 Pyrrolotriazolopyrimidinone derivatives
06/13/2006US7060731 Such as meglumine, 3-methylamino-1,2 propandiol or 2-(methylamino)-ethanol as complement inhibitors, to combact activation of the kinin/kallikrein system or as an anticoagulant
06/13/2006US7060722 Proline derivatives and use thereof as drugs
06/13/2006US7060716 Compound containing two triple bonds
06/13/2006US7060685 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/13/2006US7060305 extracts contain higher concentration of isoflavones; used to treat erectile dysfunction or malfunction